Payment overview · 2025
General Payments
$130.90
1 reported records · 1 companies
Healthcare provider profile · identity verified
Sumeesh Dhawan, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · ARLINGTON, TX · NPI 1255428827
Verified facts
What the public records show
CMS Open Payments records show Sumeesh Dhawan, M.D. received $130.90 in general payments during 2025 across 1 reported records.
Novo Nordisk Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 35 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $130.90 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $130.90 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $130.90 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 35 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
35 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 762 | 185 |
| Levothyroxine Sodium | Levothyroxine Sodium | 483 | 102 |
| Amlodipine Besylate | Amlodipine Besylate | 434 | 115 |
| Eliquis | Apixaban | 406 | 55 |
| Gabapentin | Gabapentin | 376 | 84 |
| Furosemide | Furosemide | 344 | 77 |
| Potassium Chloride | Potassium Chloride | 312 | 63 |
| Carvedilol | Carvedilol | 289 | 60 |
| Pantoprazole Sodium | Pantoprazole Sodium | 285 | 85 |
| Metformin Hcl | Metformin Hcl | 281 | 70 |
| Losartan Potassium | Losartan Potassium | 223 | 62 |
| Tramadol Hcl | Tramadol Hcl | 220 | 58 |
| Tamsulosin Hcl | Tamsulosin Hcl | 218 | 46 |
| Mirtazapine | Mirtazapine | 210 | 46 |
| Escitalopram Oxalate | Escitalopram Oxalate | 196 | 48 |
| Lisinopril | Lisinopril | 190 | 43 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 188 | 78 |
| Clopidogrel | Clopidogrel Bisulfate | 187 | 48 |
| Sertraline Hcl | Sertraline Hcl | 185 | 34 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 176 | 46 |
| Trazodone Hcl | Trazodone Hcl | 172 | 41 |
| Metoprolol Tartrate | Metoprolol Tartrate | 166 | 43 |
| Buspirone Hcl | Buspirone Hcl | 159 | 29 |
| Donepezil Hcl | Donepezil Hcl | 156 | 24 |
| Memantine Hcl | Memantine Hcl | 144 | 21 |
| Divalproex Sodium | Divalproex Sodium | 136 | 26 |
| Omeprazole | Omeprazole | 132 | 43 |
| Metoprolol Succinate | Metoprolol Succinate | 128 | 41 |
| Pregabalin | Pregabalin | 110 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 105 | 38 |
| Montelukast Sodium | Montelukast Sodium | 102 | 33 |
| Famotidine | Famotidine | 100 | 23 |
| Alprazolam | Alprazolam | 98 | 23 |
| Celecoxib | Celecoxib | 92 | 38 |
| Gemtesa | Vibegron | 90 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 90 | 27 |
| Simvastatin | Simvastatin | 89 | 19 |
| Levetiracetam | Levetiracetam | 88 | 15 |
| Methocarbamol | Methocarbamol | 86 | 30 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 84 | 18 |
| Lubiprostone | Lubiprostone | 84 | 13 |
| Bupropion Xl | Bupropion Hcl | 83 | 15 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 81 | 28 |
| Duloxetine Hcl | Duloxetine Hcl | 79 | 21 |
| Finasteride | Finasteride | 79 | 17 |
| Farxiga | Dapagliflozin Propanediol | 74 | 12 |
| Spironolactone | Spironolactone | 73 | 23 |
| Hydrochlorothiazide | Hydrochlorothiazide | 72 | 14 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 71 | 28 |
| Xarelto | Rivaroxaban | 69 | suppressed |
| Entresto | Sacubitril/Valsartan | 66 | 13 |
| Jardiance | Empagliflozin | 66 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 65 | 12 |
| Myrbetriq | Mirabegron | 65 | suppressed |
| Latanoprost | Latanoprost | 62 | 15 |
| Prednisone | Prednisone | 61 | 31 |
| Alendronate Sodium | Alendronate Sodium | 60 | 17 |
| Pravastatin Sodium | Pravastatin Sodium | 60 | 17 |
| Sucralfate | Sucralfate | 59 | 11 |
| Allopurinol | Allopurinol | 58 | 16 |
| Trulicity | Dulaglutide | 58 | 11 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 57 | 22 |
| Bumetanide | Bumetanide | 55 | 13 |
| Glimepiride | Glimepiride | 54 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 54 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 51 | 14 |
| Lorazepam | Lorazepam | 51 | 18 |
| Januvia | Sitagliptin Phosphate | 50 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 50 | 45 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 49 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 47 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 47 | 29 |
| Aripiprazole | Aripiprazole | 46 | suppressed |
| Clonazepam | Clonazepam | 46 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 45 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 45 | suppressed |
| Lamotrigine | Lamotrigine | 45 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 45 | 18 |
| Baclofen | Baclofen | 44 | 12 |
| Meloxicam | Meloxicam | 44 | 13 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 43 | 15 |
| Digoxin | Digoxin | 43 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 43 | 13 |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 42 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 40 | 27 |
| Lidocaine | Lidocaine | 40 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 40 | 14 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 39 | 19 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 39 | 13 |
| Nifedipine Er | Nifedipine | 39 | 13 |
| Sodium Chloride | 0.9 % Sodium Chloride | 39 | 19 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 38 | 24 |
| Fenofibrate | Fenofibrate | 38 | 11 |
| Nyamyc | Nystatin | 38 | 14 |
| Insulin Aspart Flexpen | Insulin Aspart | 37 | 14 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 37 | suppressed |
| Metolazone | Metolazone | 37 | 12 |
| Quetiapine Fumarate | Quetiapine Fumarate | 37 | 11 |
| Folic Acid | Folic Acid | 36 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 35 | 12 |
| Ozempic | Semaglutide | 35 | suppressed |
| Atenolol | Atenolol | 32 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 32 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 32 | 23 |
| Azithromycin | Azithromycin | 31 | 26 |
| Glipizide | Glipizide | 31 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 30 | 24 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 30 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 29 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 28 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 28 | suppressed |
| Ondansetron Odt | Ondansetron | 27 | 18 |
| Tizanidine Hcl | Tizanidine Hcl | 26 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 25 | suppressed |
| Calcitriol | Calcitriol | 25 | suppressed |
| Clozapine | Clozapine | 25 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 25 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 25 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 24 | suppressed |
| Timolol Maleate | Timolol Maleate | 24 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 23 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 23 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 23 | 13 |
| Pioglitazone Hcl | Pioglitazone Hcl | 23 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Entacapone | Entacapone | 22 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 22 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 22 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 22 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 21 | suppressed |
| Lacosamide | Lacosamide | 21 | suppressed |
| Repatha Syringe | Evolocumab | 21 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 20 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 20 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 20 | suppressed |
| Methotrexate | Methotrexate Sodium | 20 | suppressed |
| Ezetimibe | Ezetimibe | 19 | suppressed |
| Olmesartan-Amlodipine-Hctz | Olmesartan/Amlodipin/Hcthiazid | 19 | suppressed |
| Topiramate | Topiramate | 19 | suppressed |
| Budesonide | Budesonide | 18 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 18 | suppressed |
| Modafinil | Modafinil | 18 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 18 | suppressed |
| Cefdinir | Cefdinir | 17 | 14 |
| Diclofenac Sodium | Diclofenac Sodium | 17 | 11 |
| Lactulose | Lactulose | 17 | suppressed |
| Levemir | Insulin Detemir | 17 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 17 | suppressed |
| Ertapenem | Ertapenem Sodium | 16 | suppressed |
| Galantamine Er | Galantamine Hbr | 16 | suppressed |
| Nystatin | Nystatin | 16 | 12 |
| Primidone | Primidone | 16 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 16 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 16 | suppressed |
| Cephalexin | Cephalexin | 15 | 11 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 15 | suppressed |
| Dutasteride | Dutasteride | 15 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 15 | suppressed |
| Risperidone | Risperidone | 15 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 15 | suppressed |
| Dexamethasone | Dexamethasone | 14 | 11 |
| Levemir Flexpen | Insulin Detemir | 14 | suppressed |
| Loteprednol Etabonate | Loteprednol Etabonate | 14 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 14 | suppressed |
| Amantadine | Amantadine Hcl | 13 | suppressed |
| Linzess | Linaclotide | 13 | suppressed |
| Trijardy Xr | Empaglifloz/Linaglip/Metformin | 13 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 13 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 12 | suppressed |
| Fluconazole | Fluconazole | 12 | 12 |
| Humalog | Insulin Lispro | 12 | suppressed |
| Insulin Degludec Pen (U-100) | Insulin Degludec | 12 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Novolog Flexpen | Insulin Aspart | 12 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 12 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 12 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 12 | suppressed |
| Anastrozole | Anastrozole | 11 | suppressed |
| Armodafinil | Armodafinil | 11 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 11 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 11 | suppressed |
| Naloxone Hcl | Naloxone Hcl | 11 | 11 |
| Nitroglycerin | Nitroglycerin | 11 | suppressed |
| Repatha Sureclick | Evolocumab | 11 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 11 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 11 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $130.90 · 1 records | Novo Nordisk Inc | Ozempic | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error